nadia harbeck comments on monarch 2 & monaleesa-3 trial results as game changers
Published 4 years ago • 219 plays • Length 3:53Download video MP4
Download video MP3
Similar videos
-
5:34
monarch 2: overall survival of abemaciclib plus fulvestrant in hr , her2- advanced breast cancer
-
6:44
overall survival (os) results of the phase iii monaleesa-3 trial
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
16:52
everything you need to know about anastrazole and letrozole || dr liz o'riordan
-
27:28
my cancer is back (spine metastasis) - stage 4 breast cancer reoccurrence
-
7:45
kisqali® (ribociclib) mechanism of action in metastatic breast cancer for patients
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
1:19
monaleesa-2: improved os seen in hr advanced breast cancer treated with ribociclib letrozole
-
2:40
dr. hortobagyi on monaleesa-2 trial results in breast cancer
-
1:06
dr. neven on the design of the monaleesa-3 trial in advanced breast cancer
-
2:26
updated results of the monaleesa-2 trial in hr /her2- breast cancer
-
2:27
results of the monaleesa-2 study in advanced breast cancer
-
1:50
dr lynce on ongoing trials evaluating novel combinations in inflammatory breast cancer
-
12:30
nadia harbeck, münchen: überblick therapie triple positives mammakarzinom
-
1:33
dr. gabriel hortobagyi on the impact of monaleesa-2 trial in hr breast cancer
-
5:47
nadia harbeck, münchen: monaleesa 7: überlebensvorteil für prämenopausale frauen mit ribociclib
-
0:50
next steps beyond the monarch 1 trial in breast cancer
-
2:20
an overview of the monarch and neomonarch trials in breast cancer
-
13:54
overall survival results from monaleesa-2: endocrine therapy and ribociclib in hr positive and h...